This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Aetna a Step Closer to CVS Merger, Sells Medicare Business
by Zacks Equity Research
Aetna (AET) gets a step closer to its merger with CVS Health by selling its Medicare business to WellCare Health.
Are M&As Helping U.S. Markets Amid Trade War Fears?
by Ritujay Ghosh
This year so far has already seen quite a few big acquisitions, which is helping the broader market.
3 MedTech Stocks for Safe Returns as Hurricane Fears Peak
by Sweta Jaiswal
With the hurricane season at the peak, we bring three safe picks for investors.
Cigna Moves Closer to Express Scripts Buyout With DoJ Nod
by Zacks Equity Research
Cigna (CI) clears a significant regulatory hurdle with regards to its proposed acquisition of Express Scripts.
CVS Health (CVS) PBM Strengthens, Aetna Deal Shows Promise
by Zacks Equity Research
A robust 2019 PBM selling season is a tailwind for CVS Health (CVS). Additionally, the company's milestone acquisition of Aetna might alter the whole healthcare landscape in the United States.
The Zacks Analyst Blog Highlights: JPMorgan, Mastercard, AbbVie, CVS Health and Estee Lauder
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JPMorgan, Mastercard, AbbVie, CVS Health and Estee Lauder
Top Stock Reports for JPMorgan, Mastercard & AbbVie
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan (JPM), Mastercard (MA) and AbbVie (ABBV).
CVS Health (CVS) Up 10.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Medical Services Boom Drives Healthcare: 3 Top Picks
by Sreyoshi Mukherjee
Considering the rising popularity of PBM, CRO and EHR in the U.S. Medical Services industry, these three picks might be money-spinning choices for investors.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $74.08, moving +0.58% from the previous trading session.
Are M&As the Secret Mantra Propelling US Markets' Bull-Run?
by Ritujay Ghosh
Given the bullish economic outlook, robust corporate earnings and interest rates still remaining low in the United States, companies are going for mergers for future growth.
Pharmacies and Drug Stores Stock Outlook: Prospects Bright
by Zacks Equity Research
Amazon's entry into drug distribution is expected be a game changer but the immediate implications will be limited, given that the healthcare space is highly complex and regulated.
Walmart Soared, But Amazon (AMZN) Stock Is Still a Must Buy
by Benjamin Rains
Walmart (WMT) saw its stock price surge over 10% Thursday after the retail giant reported stronger-than-anticipated quarterly financial results. Yet, while some investors dive into WMT stock, the e-commerce powerhouse that forced Walmart to revamp its business model seems as strong as ever. So let's see why Amazon (AMZN) stock looks like a great buy right now.
CVS Health's PBM Selling Season Strong, Aetna Deal on Track
by Zacks Equity Research
A solid 2019 PBM selling season is a significant positive for CVS Health's (CVS) growth. The company completes more than 70% of its client renewals, almost in line with the prior-year level.
UnitedHealth to Spread in Pharmacy Business With Genoa Deal
by Zacks Equity Research
UnitedHealth's (UNH) acquisition of Genoa Health should aid the company's Optum segment.
Time to Buy Kroger (KR) Stock After Alibaba (BABA) Partnership?
by Benjamin Rains
Shares of Kroger (KR) surged over 2.3% Tuesday to inch close to their 52-week high after the company announced a partnership with Chinese e-commerce powerhouse and Amazon (AMZN) rival Alibaba (BABA). The deal marks the U.S. grocery giant's first push into international markets and represents the continuation of a much larger e-commerce venture.
Top Research Reports with Q2 Earnings Analysis: Merck, CVS Health, CME Group & More
by Kalyan Nandy
Today's Research Daily features updated research reports on 16 major stocks, including Merck (MRK), CVS Health (CVS) and CME Group (CME).
CVS Health's (CVS) Q2 Earnings Beat Estimate, Margins Up
by Zacks Equity Research
CVS Health (CVS) reports strong Pharmacy Services revenues, benefiting from the upside in the specialty services. Year-over-year Retail/LTC comparisons are also encouraging.
Stock Index Futures Lower On Wednesday
by Zacks Equity Research
Stock Index Futures Lower On Wednesday
Indexes Start Lower As Trade Worries Persist
by Zacks Equity Research
U.S. stock index futures were lower on Wednesday as global trade war fears continue to dent investor confidence despite a robust second-quarter 2018 earnings season
Buy These 6 Low Price-to-Book Stocks for Handsome Returns
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
CVS Health (CVS) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 4.97% and 0.68%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Buy Amazon (AMZN) Stock On Possible Gas Station & Travel Push?
by Benjamin Rains
Shares of Amazon (AMZN) popped Tuesday after D.A. Davidson analysts suggested that the next logical industries for the e-commerce giant to enter would be gas stations and travel. Amazon could likely jump into the gas station market without much fuss, similar to Costco (COST), and certainly has the online infrastructure and customer base to offer travel deals. But what should investors make of this?
Should Value Investors Pick CVS Health (CVS) Stock Now?
by Zacks Equity Research
Let's see if CVS Health Corporation (CVS) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Rite Aid Stock Falls on FY19 View Cut Ahead of Merger Vote
by Zacks Equity Research
Rite Aid (RAD) lowers fiscal 2019 guidance as the generic drug purchasing efficiencies fall below expectations. Rite Aid shareholders are likely to vote for the Albertsons merger on Aug 9.